Cargando…
Mycobacterium abscessus and β-Lactams: Emerging Insights and Potential Opportunities
β-lactams, the most widely used class of antibiotics, are well-tolerated, and their molecular mechanisms of action against many bacteria are well-documented. Mycobacterium abscessus (Mab) is a highly drug-resistant rapidly-growing nontuberculous mycobacteria (NTM). Only in recent years have we start...
Autores principales: | Story-Roller, Elizabeth, Maggioncalda, Emily C., Cohen, Keira A., Lamichhane, Gyanu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167491/ https://www.ncbi.nlm.nih.gov/pubmed/30319581 http://dx.doi.org/10.3389/fmicb.2018.02273 |
Ejemplares similares
-
803. Overcoming β-Lactam Resistance in Mycobacterium abscessus
por: Story-Roller, Elizabeth, et al.
Publicado: (2018) -
A mouse model of pulmonary Mycobacteroides abscessus infection
por: Maggioncalda, Emily C., et al.
Publicado: (2020) -
T405, a New Penem, Exhibits In Vivo Efficacy against M. abscessus and Synergy with β-Lactams Imipenem and Cefditoren
por: Rimal, Binayak, et al.
Publicado: (2022) -
Development of a penem antibiotic against Mycobacteroides abscessus
por: Batchelder, Hunter R., et al.
Publicado: (2020) -
Potency of Omadacycline against Mycobacteroides abscessus Clinical Isolates In Vitro and in a Mouse Model of Pulmonary Infection
por: Nicklas, Danielle A., et al.
Publicado: (2022)